The herpesvirus encoded dUTPase as a potential chemotherapeutic target.
The human herpesviruses are a well characterized group of viruses that are responsible for a wide spectrum of human diseases. Included in this group of pathogens are the alphaherpesviruses (herpes simplex types 1 and 2 and varicella-zoster virus), the betaherpesviruses (cytomegalovirus, human herpesvirus types 6 and 7) and the gammaherpesviruses (Epstein-Barr virus and human herpesvirus 8). An important feature of these viruses is that they cause latent infections that can be reactivated to cause disease. The herpesviruses encode for a large number of structural and non-structural proteins, and several of the non-structural proteins, such as thymidine kinase, DNA polymerase, and ribonucleotide reductase, have been utilized as targets for the development of anti-herpesvirus agents. Another herpesvirus encoded enzyme that has received little attention as a potential target for the development of specific anti-herpesvirus agents is deoxyuridine triphosphate nucleotidohydrolase (dUTPase). Furthermore, little is known concerning the role of the herpesviruses' encoded dUTPases in virus replication and in modulating the chemotherapeutic efficiency of other anti-herpes agents. Because of recent advances in molecular virology and biochemistry, it is now possible to rationally develop "designer" drugs based upon the structural/functional interaction of the drug with a specific viral protein. The purpose of this review is to describe previous studies demonstrating the potential use of the herpesvirus encoded dUTPase as a drug target, to describe problems associated with using the dUTPase as a target and to discuss new approaches that can be used.
Studebaker
A W
AW
Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, 2074 Graves Hall, 333 West 10th Avenue, Columbus, OH 43210, USA.
Balendiran
G K
GK
Williams
M V
MV
D000998:Antiviral Agents / Q000494:pharmacology*; D045647:DNA Glycosylases; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006564:Herpesviridae / Q000201:enzymology* / Q000235:genetics / Q000378:metabolism; D006566:Herpesviridae Infections / Q000188:drug therapy*; D008274:Magnesium / Q000378:metabolism; D009699:N-Glycosyl Hydrolases / Q000235:genetics / Q000378:metabolism; D017434:Protein Structure, Tertiary; D011755:Pyrophosphatases / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D013379:Substrate Specificity; D051981:Uracil-DNA Glycosidase; D014779:Virus Replication / Q000502:physiology
D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D045647:DNA Glycosylases; D009699:N-Glycosyl Hydrolases; D051981:Uracil-DNA Glycosidase; D011755:Pyrophosphatases; C020020:dUTP pyrophosphatase; D008274:Magnesium